Literature DB >> 9130595

Cux/CDP homeodomain protein binds to an enhancer in the rat c-mos locus and represses its activity.

N A Higgy1, H A Tarnasky, I Valarché, A Nepveu, F A van der Hoorn.   

Abstract

The c-mos gene is transcribed in male and female germ cells, in differentiating myoblasts and in 3T3 cells from cell-specific promoters. We characterized the rat testis promoter, which contains a TATA-box and one binding site for a testis-specific transcription factor TTF-D, as well as a region which can act as enhancer, which is located approx. 2 kb upstream of the c-mos AUG start codon. It binds three factors at sites I, II and III as determined in DNAse I footprint assays. We demonstrated that a member of the NF-1/CTF family of transcription factors binds site II. Here we report the cloning of the protein that binds to enhancer site III. This protein is the rat homolog of human hCut/CDP, mouse Cux/CDP and canine Clox. hCut/Cux/CDP/Clox (hereafter called Cux/CDP), a 160 kDa protein containing multiple repeats and a homeodomain, negatively regulates the mammalian c-myc, gp91-phox and N-Cam genes. Using bacterially produced murine GST-Cux fusion proteins and GST-Cux deletion mutants, we find that Cux repeat CR3 and the homeodomain are both required for efficient binding to enhancer site III. Mouse lung and testis nuclear Cux/CDP bind to site III as determined in electrophoretic gel mobility supershift assays using two different anti-hCut specific monoclonal antibodies. Transfections of CAT constructs containing the enhancer fragment linked to a minimal promoter demonstrated that Cux/CDP represses c-mos enhancer activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130595     DOI: 10.1016/s0167-4781(96)00221-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Hepatomegaly in transgenic mice expressing the homeobox gene Cux-1.

Authors:  Gregory B Vanden Heuvel; Jennifer G Brantley; Neal I Alcalay; Madhulika Sharma; Gabor Kemeny; Joshua Warolin; Aric W Ledford; David M Pinson
Journal:  Mol Carcinog       Date:  2005-05       Impact factor: 4.784

2.  CDP/Cux stimulates transcription from the DNA polymerase alpha gene promoter.

Authors:  Mary Truscott; Lélia Raynal; Peter Premdas; Brigitte Goulet; Lam Leduy; Ginette Bérubé; Alain Nepveu
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

3.  Homeoproteins CDP and SATB1 interact: potential for tissue-specific regulation.

Authors:  J Liu; A Barnett; E J Neufeld; J P Dudley
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

4.  Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasia.

Authors:  Aric W Ledford; Jennifer G Brantley; Gabor Kemeny; Tonia L Foreman; Susan E Quaggin; Peter Igarashi; Stephanie M Oberhaus; Marianna Rodova; James P Calvet; Gregory B Vanden Heuvel
Journal:  Dev Biol       Date:  2002-05-01       Impact factor: 3.582

5.  CDP is a repressor of mouse mammary tumor virus expression in the mammary gland.

Authors:  Q Zhu; K Gregg; M Lozano; J Liu; J P Dudley
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  The homeodomain protein Cux1 interacts with Grg4 to repress p27 kip1 expression during kidney development.

Authors:  Madhulika Sharma; Jennifer G Brantley; Dianne Vassmer; Gaurav Chaturvedi; Jennifer Baas; Gregory B Vanden Heuvel
Journal:  Gene       Date:  2009-03-28       Impact factor: 3.688

7.  High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1.

Authors:  Maria Fragiadaki; Tetsurou Ikeda; Abigail Witherden; Roger M Mason; David Abraham; George Bou-Gharios
Journal:  Mol Biol Cell       Date:  2011-04-06       Impact factor: 4.138

8.  CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation.

Authors:  Heidi Griesmann; Sebastian Mühl; Jan Riedel; Katharina Theuerkorn; Bence Sipos; Irene Esposito; Gregory B Vanden Heuvel; Patrick Michl
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.